Dose Optimization of Rivaroxaban Combined With Rifampicin
Clinical trial NCT05658042 · UNKNOWN
Trial details
- NCT number
- NCT05658042
- Sponsor
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2022-07-01
- Primary completion
- 2024-06-30
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.